Back to Browse Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 3 » Issue 4

Long-acting β2-agonists (LABA) in chronic obstructive pulmonary disease: efficacy and safety

Authors Andrea Rossi, Sonia Khirani, Mario Cazzola

Published 5 December 2008 Volume 2008:3(4) Pages 521—529


Andrea Rossi1, Sonia Khirani1, Mario Cazzola2

1Unit of Respiratory Diseases, Hospital of Bergamo, Bergamo, Italy; 2Unit of Respiratory Diseases, Department of Internal Medicine, University of Rome ‘Tor Vergata’, Rome, Italy

Abstract: COPD is characterized by progressive airflow obstruction which does not fully reverse to inhaled or oral pharmacotherapy. The management of patients with COPD has taken a totally new direction over the past 20 years, thank to the use of novel therapies aimed to improve and modify the natural history of COPD. Long-acting bronchodilators, including long-acting β2-agonists (LABAs), were introduced several years ago in order to enhance improvements in lung function, health status related quality of life, and reduce the rate of exacerbations. These effects can be boosted by the combination of LABAs with long-acting anticholinergic, and/or with inhaled corticosteroids. Inhaled LABAs are commonly well tolerated although adverse effects such as tremor and palpitations are occasionally troublesome.

Keywords: LABA, COPD, efficacy, safety

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 


Readers of this article also read:

Severe agitation in severe early-onset Alzheimer’s disease resolves with ECT

Aksay SS, Hausner L, Frölich L, Sartorius A

Neuropsychiatric Disease and Treatment 2014, 10:2147-2151

Published Date: 13 November 2014

Magnetic seizure therapy in an adolescent with refractory bipolar depression: a case report

Noda Y, Daskalakis ZJ, Downar J, Croarkin PE, Fitzgerald PB, Blumberger DM

Neuropsychiatric Disease and Treatment 2014, 10:2049-2055

Published Date: 31 October 2014

Toxicology of antimicrobial nanoparticlesfor prosthetic devices

Nuñez-Anita RE, Acosta-Torres LS, Vilar-Pineda J, Martínez-Espinosa JC, de la Fuente-Hernández J, Castaño VM

International Journal of Nanomedicine 2014, 9:3999-4006

Published Date: 20 August 2014

Nanoparticles containing allotropes of carbon have genotoxic effects on glioblastomamultiforme cells

Hinzmann M, Jaworski S, Kutwin M, Jagiełło J, Koziński R, Wierzbicki M, Grodzik M, Lipińska L, Sawosz E, Chwalibog A

International Journal of Nanomedicine 2014, 9:2409-2417

Published Date: 15 May 2014

Chemotherapeutic potential of curcumin-bearing microcells against hepatocellular carcinoma in model animals

Farazuddin M, Dua B, Zia Q, Khan AA, Joshi B, Owais M

International Journal of Nanomedicine 2014, 9:1139-1152

Published Date: 3 March 2014

Possible association between haplotypes of the FKBP5 gene and suicidal bipolar disorder, but not with melancholic depression and psychotic features, in the course of bipolar disorder

Leszczyńska-Rodziewicz A, Szczepankiewicz A, Narożna B, Skibińska M, Pawlak J, Dmitrzak-Węglarz M, Hauser J

Neuropsychiatric Disease and Treatment 2014, 10:243-248

Published Date: 3 February 2014

Writing 3D patterns of microvessels

Juodkazis S

International Journal of Nanomedicine 2012, 7:3701-3702

Published Date: 13 July 2012

Local gene delivery via endovascular stents coated with dodecylated chitosan–plasmid DNA nanoparticles

Dunwan Zhu, Xu Jin, Xigang Leng, et al

International Journal of Nanomedicine 2010, 5:1095-1102

Published Date: 6 December 2010

Benefit of magnesium-25 carrying porphyrin-fullerene nanoparticles in experimental diabetic neuropathy

Asieh Hosseini, Mohammad Sharifzadeh, Seyed Mahdi Rezayat, et al

International Journal of Nanomedicine 2010, 5:517-523

Published Date: 16 July 2010